Correlation Between Integral and Dicerna Pharmaceuticals

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Integral and Dicerna Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Integral and Dicerna Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Integral Ad Science and Dicerna Pharmaceuticals, you can compare the effects of market volatilities on Integral and Dicerna Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Integral with a short position of Dicerna Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Integral and Dicerna Pharmaceuticals.

Diversification Opportunities for Integral and Dicerna Pharmaceuticals

0.0
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Integral and Dicerna is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Integral Ad Science and Dicerna Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Dicerna Pharmaceuticals and Integral is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Integral Ad Science are associated (or correlated) with Dicerna Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Dicerna Pharmaceuticals has no effect on the direction of Integral i.e., Integral and Dicerna Pharmaceuticals go up and down completely randomly.

Pair Corralation between Integral and Dicerna Pharmaceuticals

If you would invest (100.00) in Dicerna Pharmaceuticals on September 12, 2024 and sell it today you would earn a total of  100.00  from holding Dicerna Pharmaceuticals or generate -100.0% return on investment over 90 days.
Time Period3 Months [change]
DirectionFlat 
StrengthInsignificant
Accuracy0.0%
ValuesDaily Returns

Integral Ad Science  vs.  Dicerna Pharmaceuticals

 Performance 
       Timeline  
Integral Ad Science 

Risk-Adjusted Performance

1 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Integral Ad Science are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively stable basic indicators, Integral is not utilizing all of its potentials. The current stock price uproar, may contribute to short-horizon losses for the private investors.
Dicerna Pharmaceuticals 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Dicerna Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong basic indicators, Dicerna Pharmaceuticals is not utilizing all of its potentials. The latest stock price disturbance, may contribute to short-term losses for the investors.

Integral and Dicerna Pharmaceuticals Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Integral and Dicerna Pharmaceuticals

The main advantage of trading using opposite Integral and Dicerna Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Integral position performs unexpectedly, Dicerna Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Dicerna Pharmaceuticals will offset losses from the drop in Dicerna Pharmaceuticals' long position.
The idea behind Integral Ad Science and Dicerna Pharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Risk-Return Analysis module to view associations between returns expected from investment and the risk you assume.

Other Complementary Tools

Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins